ISOFOL.ST
Healthcare BiotechnologyIsofol Medical AB (publ)
SEK 0.79
+0.03 +4.50% today
Price History
Not enough data
Key Stats
Market Cap
252.87M
Avg Volume
462,838
EPS
-SEK 0.20
52W High
SEK 0.99
52W Low
SEK 0.55
Div. Yield
0.0%
Valuation
Forward P/E
-15.78
P/B Ratio
2.67
Margins
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
EBITDA Margin 0.0%
Growth & Returns
Return on Equity
(78.3%)
Return on Assets
(39.0%)
Liquidity & Leverage
Current Ratio
5.17
Quick Ratio
5.11
Total Cash
114.83M
Total Debt
0
About
Isofol Medical AB (publ) operates as a clinical stage biotech company. It develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. The company was incorporated in 2008 and is based in Gothenburg, Sweden.
isofolmedical.com